Recent Updates
Recently added Catalysts
KIDS Positive Sentiment Score: 75/100

OrthoPediatrics to Participate in the Canaccord Genuity 46th Annual Growth Conference

Key Takeaway: OrthoPediatrics Corp. has announced its participation in the Canaccord Genuity 46th Annual Growth Conference. CEO Dave Bailey and CFO Fred Hite will engage in a fireside chat on August 12, 2026, at 9:00 am ET. An audio webcast will be available on the company's investor relations website, along with a replay post-event.

Market Sentiment Analysis

POSITIVE FACTORS

  • OrthoPediatrics is actively participating in a prominent growth conference.
  • The company is focused on advancing pediatric orthopedics, which is a niche market.
  • The event provides an opportunity for leadership to engage with investors.

Full Press Release Details

WARSAW, Ind., July 29, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that Dave Bailey, President & Chief Executive Officer, and Fred Hite, Chief Operating Officer, and Chief Financial Officer, are scheduled to participate in a fireside chat at the Canaccord Genuity 46 th Annual Growth Conference, held in Boston, MA.

Event: Canaccord Genuity 46 th Annual Growth Conference Format: Fireside Chat Date: Wednesday, August 12, 2026 Time: 9:00 am ET

An audio webcast of the discussion will be available online at the OrthoPediatrics’ investor relations website, http://ir.orthopediatrics.com. Additionally, a replay will be available after the event.
About OrthoPediatrics Corp. Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such, it has developed the most comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets over 90 systems that serve three of the largest categories within the pediatric orthopedic market. This product offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and over 75 countries outside the United States. For more information, please visit www.orthopediatrics.com. For more information about the OrthoPediatrics Specialty Bracing portfolio, please visit www.opsb.com.

Investor Contact Philip Trip Taylor Gilmartin Group philip@gilmartinir.com 415-937-5406

Frequently Asked Questions

When is the Canaccord Genuity conference?

The conference is scheduled for August 12, 2026.

Who will represent OrthoPediatrics at the event?

CEO Dave Bailey and CFO Fred Hite will represent the company.

How can I access the conference audio?

An audio webcast will be available on the OrthoPediatrics investor relations website.

What is the focus of OrthoPediatrics?

OrthoPediatrics focuses exclusively on pediatric orthopedics.

Last updated: Jul 29, 2026